ICTRP Search Portal

Main

Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.

Register:	JPRN
Last refreshed on:	17 October 2023
Main ID:	JPRN-UMIN000016950
Date of registration:	03/04/2015
Prospective Registration:	No
Primary sponsor:	Osaka Medical College
Public title:	Clinical outcome in patients with rheumatoid arthritis switched to tumor nesrosis factor blockers after tocilizumab or abatacept
Scientific title:	Clinical outcome in patients with rheumatoid arthritis switched to tumor nesrosis factor blockers after tocilizumab or abatacept - Clinical outcome in patients with RA switched to TNF blocker after tocilizumab or abatacept
Date of first enrolment:	2015/03/27
Target sample size:	50
Recruitment status:	Complete: follow-up complete
URL:	https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019675
Study type:	Interventional
Study design:	Single arm Non-randomized
Phase:	Not selected

Countries of recruitment
Japan

Contacts

Name:	Shuzo Yoshida
Address:	2-7 Daigakumachi, Takatsuki city, Osaka 569-8686, Japan Japan
Telephone:	072-683-1221
Email:	in1307@osaka-med.ac.jp
Affiliation:	Osaka Medical College Department of Internal Medicine (I)

Name:	Shuzo Yoshida
Address:	2-7 Daigakumachi, Takatsuki city, Osaka 569-8686, Japan Japan
Telephone:	072-683-1221
Email:	in1307@poh.osaka-med.ac.jp
Affiliation:	Osaka Medical College Department of Internal Medicine (I)

Key inclusion & exclusion criteria

Inclusion criteria:
Exclusion criteria: none

Age minimum: 20years-old
Age maximum: Not applicable
Gender: Male and Female

Health Condition(s) or Problem(s) studied

rheumatoid arthritis

Intervention(s)

Infliximab or adalimumab or golimumab

Primary Outcome(s)

Clinical remission rate in 48w (DAS28ESR<2.6)

Secondary Outcome(s)

Power Dopper signal

Secondary ID(s)

Source(s) of Monetary Support

none

Secondary Sponsor(s)

Ethics review

Status: YES
Approval date:
Contact:

Results

Results available:
Date Posted:
Date Completed:
URL:

Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.